Related Experiment Video
Updated: Jul 18, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
Abstract:
Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.
Insights
Tumour necrosis factor (TNF) has shown disappointing results in cancer treatment. However, improved patient selection and tailored therapies may still offer therapeutic benefits.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Tumour necrosis factor (TNF) is a pro-inflammatory cytokine with a complex role in cancer.
- Initial investigations into TNF as a cancer therapeutic yielded limited success.
- The pleiotropic effects of TNF necessitate a nuanced approach to its clinical application.
Discussion:
- The broad systemic effects of TNF can lead to significant toxicity, limiting its therapeutic window.
- Understanding the specific molecular pathways influenced by TNF in different cancer types is crucial.
- Biomarkers for patient selection may help identify individuals most likely to respond to TNF-based therapies.
Key Insights:
- Direct administration of TNF has not proven broadly effective for cancer treatment.
- Patient stratification based on tumor characteristics and immune profiles is essential for potential success.
- Targeted delivery or combination therapies involving TNF may overcome previous limitations.
Outlook:
- Future research should focus on identifying predictive biomarkers for TNF response.
- Exploring novel therapeutic strategies, such as regional delivery or combination with other agents, is warranted.
- Personalized medicine approaches could unlock the potential of TNF in specific oncological settings.
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Pharmaceutical Poisoning: Treatment Strategies

